[TODO] Hook — BPC-157 as the most researched healing peptide, gastric juice-derived, broad tissue repair potential across 100+ studies
[IMAGE: BPC-157 molecular structure — 15 amino acid sequence visualization]
What is BPC-157?
- [TODO] Full name — Body Protection Compound-157, pentadecapeptide (15 amino acids)
- [TODO] Origin — isolated from human gastric juice, part of larger BPC protein
- [TODO] Molecular weight — 1419.53 Da
- [TODO] Stability — stable in gastric acid (unique for peptides), no carrier needed
- [TODO] Research scope — 100+ published studies, mostly animal models
Mechanism of Action
[IMAGE: Diagram of BPC-157 pathways — NO system, VEGF, FAK-paxillin, GH receptor interaction]
- [TODO] Nitric oxide system — modulates eNOS, promotes vasodilation and blood flow to injured tissue
- [TODO] Angiogenesis — VEGF upregulation, new blood vessel formation in damaged areas
- [TODO] FAK-paxillin pathway — cell migration and tissue repair signaling
- [TODO] Growth hormone receptor interaction — upregulates GH receptor expression
- [TODO] Anti-inflammatory — reduces TNF-alpha, modulates cytokine profile
- [TODO] GI protection — cytoprotective in gastric/intestinal mucosa
Research Highlights
- [TODO] Tendon/ligament — accelerated healing in Achilles tendon transection (rat)
- [TODO] Muscle — improved recovery after crush injury, laceration models
- [TODO] GI tract — gastric ulcer healing, IBD models, fistula repair
- [TODO] Bone — enhanced fracture healing, osteogenic activity
- [TODO] Neuroprotection — peripheral nerve repair, dopaminergic system interaction
- [TODO] Limitation — no completed human clinical trials to date
Dosing Protocols (Research Context)
- [TODO] Typical research dose — 200-800mcg/day (subcutaneous or oral)
- [TODO] Systemic vs local — SC near injury site vs systemic injection vs oral
- [TODO] Duration — 4-6 week protocols common in animal literature
- [TODO] Reconstitution — bacteriostatic water, store 2-8°C, use within 4 weeks
Safety & Considerations
- [TODO] Toxicity data — no reported LD50, no organ toxicity in animal studies
- [TODO] Side effects — minimal reported in animal literature
- [TODO] Limitations — predominantly animal data, lack of human RCTs
- [TODO] WADA status — listed on prohibited substance list (S0 category)
Häufig gestellte Fragen
[FAQ: Can BPC-157 be taken orally or is injection required?]
[FAQ: How does BPC-157 compare to TB-500 for tissue repair?]
[FAQ: What is the shelf life after reconstitution?]
[FAQ: Are there any human clinical trials for BPC-157?]
[FAQ: Does BPC-157 interact with other peptides?]
Related Products
[TODO] Link to BPC-157 product page + Healing & Recovery category